<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Viejo-Borbolla, Abel</dc:creator>
  <dc:creator>Martinez-Martín, Nadia</dc:creator>
  <dc:creator>Nel, Hendrik J.</dc:creator>
  <dc:creator>Rueda, Patricia</dc:creator>
  <dc:creator>Martín, Rocío</dc:creator>
  <dc:creator>Blanco, Soledad</dc:creator>
  <dc:creator>Arenzana-Seisdedos, Fernando</dc:creator>
  <dc:creator>Thelen, Marcus</dc:creator>
  <dc:creator>Fallon, Padraic G.</dc:creator>
  <dc:creator>Alcamí, Antonio</dc:creator>
  <dc:date>2012-02-02</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Herpes simplex virus (HSV) types 1 and 2 are highly prevalent human neurotropic  pathogens that cause a variety of diseases, including lethal encephalitis. The relationship  between HSV and the host immune system is one of the main determinants of the infection  outcome. Chemokines play relevant roles in antiviral response and immunopathology, but  the modulation of chemokine function by HSV is not well understood. We have addressed  the modulation of chemokine function mediated by HSV. By using surface plasmon  resonance and crosslinking assays we show that secreted glycoprotein G (SgG) from both  HSV-1 and HSV-2 binds chemokines with high affinity. Chemokine binding activity was also  observed in the supernatant of HSV-2 infected cells and in the plasma membrane of cells  infected with HSV-1 wild type but not with a gG deficient HSV-1 mutant. Cell-binding and  competition experiments indicate that the interaction takes place through the  glycosaminoglycan-binding domain of the chemokine. The functional relevance of the  interaction was determined both in vitro, by performing transwell assays, time-lapse  microscopy, and signal transduction experiments; and in vivo, using the air pouch model of  inflammation. Interestingly, and in contrast to what has been observed for previously  described viral chemokine binding proteins, HSV SgGs do not inhibit chemokine function.  On the contrary, HSV SgGs enhance chemotaxis both in vitro and in vivo through  increasing directionality, potency and receptor signaling. This is the first report, to our  knowledge, of a viral chemokine binding protein from a human pathogen that increases  chemokine function and points towards a previously undescribed strategy of immune  modulation mediated by viruses.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://n2t.net/ark:/12658/srd1319078</dc:identifier>
  <dc:identifier>https://susi.usi.ch/global/documents/319078</dc:identifier>
  <dc:identifier>https://susi.usi.ch/documents/319078/files/Viejo-Borbolla_PP_2012.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1371/journal.ppat.1002497</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/ark/12658/srd1319078</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>CC BY</dc:rights>
  <dc:source>Plos pathogens. - 2012, vol. 8, no. 2, p. e1002497</dc:source>
  <dc:subject>info:eu-repo/classification/udc/61</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Enhancement of chemokine function as an immunomodulatory strategy employed by human herpesviruses</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
